Advanced melanoma skin cancer diagnosis can be very scary, but this drug takes the scariness away.
In a new study by the American Society of Clinical Oncology, a new class of expensive immune-boosting drugs such as Keytruda, significantly increased the three-year survival rates for advanced melanoma patients.
Really, tell me more about these drugs.
These immunotherapy drugs are designed to bind to specific targets in the body, using one’s immune system to kill the cancer cells.
In fact, former President Jimmy Carter took one of those immunotherapy drugs, specifically Keytruda, during his successful battle with advanced melanoma which had spread to other parts of his body. President Carter had recently indicated that he showed no signs of cancer.
The study gives hope for a longer life for those with melanoma.
According to the American Cancer Society, about 76,380 new melanomas will be diagnosed (about 46,870 in men and 29,510 in women) in 2016.
The only thing that will make these class of drugs more hopeful is if they reduce the price significantly, but nevertheless it is a step closer to finding a cure for this deadly form of skin cancer, and that to me is keeping hope alive.